Q6PFW1 (VIP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 84.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 EC=2.7.4.21 EC=2.7.4.24 Alternative name(s): Diphosphoinositol pentakisphosphate kinase 1 Histidine acid phosphatase domain-containing protein 2A IP6 kinase Inositol pyrophosphate synthase 1 InsP6 and PP-IP5 kinase 1 VIP1 homolog Short name=hsVIP1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1433 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Bifunctional inositol kinase that acts in concert with the IP6K kinases IP6K1, IP6K2 and IP6K3 to synthesize the diphosphate group-containing inositol pyrophosphates diphosphoinositol pentakisphosphate, PP-InsP5, and bis-diphosphoinositol tetrakisphosphate, (PP)2-InsP4. PP-InsP5 and (PP)2-InsP4, also respectively called InsP7 and InsP8, regulate a variety of cellular processes, including apoptosis, vesicle trafficking, cytoskeletal dynamics, exocytosis, insulin signaling and neutrophil activation. Phosphorylates inositol hexakisphosphate (InsP6) at positions 1 or 3 to produce PP-InsP5 which is in turn phosphorylated by IP6Ks to produce (PP)2-InsP4. Alternatively, phosphorylates at position 1 or 3 PP-InsP5, produced by IP6Ks from InsP6, to produce (PP)2-InsP4. Activated when cells are exposed to hyperosmotic stress. Ref.7 Ref.8 Ref.9 |
| Catalytic activity | ATP + 1D-myo-inositol hexakisphosphate = ADP + 1D-myo-inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate. Ref.7 Ref.8 Ref.9 Ref.12 Ref.13 ATP + 1D-myo-inositol 1,3,4,5,6-pentakisphosphate = ADP + 1D-myo-inositol diphosphate tetrakisphosphate (isomeric configuration unknown). Ref.7 Ref.8 Ref.9 Ref.12 Ref.13 ATP + 1D-myo-inositol 5-diphosphate pentakisphosphate = ADP + 1D-myo-inositol bisdiphosphate tetrakisphosphate (isomeric configuration unknown). Ref.7 Ref.8 Ref.9 Ref.12 Ref.13 |
| Subcellular location | Cytoplasm › cytosol. Cell membrane. Note: Relocalizes to the plasma membrane upon activation of the PtdIns 3-kinase pathway. Ref.7 Ref.8 Ref.13 |
| Tissue specificity | Widely expressed, with a higher expression in skeletal muscle, heart and brain. Ref.7 |
| Domain | The polyphosphoinositide-binding domain mediates binding of PtdIns(3,4,5)P3 and InsP6. Despite its similarity with the phosphatase domain of histidine acid phosphatases, it has no phosphatase activity (Ref.13). Ref.13 |
| Sequence similarities | Belongs to the histidine acid phosphatase family. VIP1 subfamily. |
| Biophysicochemical properties | Kinetic parameters: The catalytic efficiency is 80 folds higher for 5-PP-InsP5 (InsP7) compared to InsP6. KM=0.12 µM for InsP6 Ref.7 Ref.8 Ref.13 KM=0.10 µM for InsP7 Vmax=0.03 nmol/min/mg enzyme with InsP6 as substrate Vmax=0.13 nmol/min/mg enzyme with InsP7 as substrate |
| Sequence caution | The sequence BAA20831.2 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
Alternative products
| This entry describes 7 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q6PFW1-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q6PFW1-2) The sequence of this isoform differs from the canonical sequence as follows: 818-821: Missing. 1082-1082: N → NG | ||||||
| Isoform 3 (identifier: Q6PFW1-3) The sequence of this isoform differs from the canonical sequence as follows: 818-821: Missing. 1062-1082: Missing. | ||||||
| Isoform 4 (identifier: Q6PFW1-4) The sequence of this isoform differs from the canonical sequence as follows: 653-653: Missing. 818-821: Missing. 1062-1082: Missing. | ||||||
| Isoform 5 (identifier: Q6PFW1-5) The sequence of this isoform differs from the canonical sequence as follows: 810-821: Missing. 865-957: Missing. 1107-1240: Missing. | ||||||
| Isoform 6 (identifier: Q6PFW1-6) The sequence of this isoform differs from the canonical sequence as follows: 818-1433: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 7 (identifier: Q6PFW1-7) The sequence of this isoform differs from the canonical sequence as follows: 818-821: Missing. 1020-1082: Missing. 1167-1167: Y → LETRFCHVGQAGLELLTSSDLPASASQSAGITGVSHRTQPD | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1433 | 1433 | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 | PRO_0000315688 | |||||
Regions | |||||||||
| Nucleotide binding | 248 – 251 | 4 | ATP By similarity | ||||||
| Nucleotide binding | 257 – 259 | 3 | ATP By similarity | ||||||
| Nucleotide binding | 332 – 334 | 3 | ATP By similarity | ||||||
| Region | 64 – 65 | 2 | Substrate binding By similarity | ||||||
| Region | 224 – 225 | 2 | Substrate binding By similarity | ||||||
| Region | 337 – 340 | 4 | Substrate binding By similarity | ||||||
| Region | 382 – 453 | 72 | Polyphosphoinositide-binding domain | ||||||
Sites | |||||||||
| Binding site | 145 | 1 | ATP By similarity | ||||||
| Binding site | 198 | 1 | ATP By similarity | ||||||
| Binding site | 205 | 1 | ATP By similarity | ||||||
| Binding site | 224 | 1 | ATP By similarity | ||||||
| Binding site | 259 | 1 | Substrate By similarity | ||||||
| Binding site | 273 | 1 | Substrate By similarity | ||||||
| Binding site | 275 | 1 | ATP By similarity | ||||||
| Binding site | 320 | 1 | ATP By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 1152 | 1 | Phosphoserine Ref.10 | ||||||
Natural variations | |||||||||
| Alternative sequence | 653 | 1 | Missing in isoform 4. | VSP_030615 | |||||
| Alternative sequence | 810 – 821 | 12 | Missing in isoform 5. | VSP_030616 | |||||
| Alternative sequence | 818 – 1433 | 616 | Missing in isoform 6. | VSP_030617 | |||||
| Alternative sequence | 818 – 821 | 4 | Missing in isoform 2, isoform 3, isoform 4 and isoform 7. | VSP_030618 | |||||
| Alternative sequence | 865 – 957 | 93 | Missing in isoform 5. | VSP_030619 | |||||
| Alternative sequence | 1020 – 1082 | 63 | Missing in isoform 7. | VSP_030620 | |||||
| Alternative sequence | 1062 – 1082 | 21 | Missing in isoform 3 and isoform 4. | VSP_030621 | |||||
| Alternative sequence | 1082 | 1 | N → NG in isoform 2. | VSP_030622 | |||||
| Alternative sequence | 1107 – 1240 | 134 | Missing in isoform 5. | VSP_030623 | |||||
| Alternative sequence | 1167 | 1 | Y → LETRFCHVGQAGLELLTSSD LPASASQSAGITGVSHRTQP D in isoform 7. | VSP_030624 | |||||
Experimental info | |||||||||
| Mutagenesis | 399 | 1 | R → A: Decreases 8-fold the affinity for PtdIns(3,4,5)P3. Ref.13 | ||||||
| Mutagenesis | 417 | 1 | R → A: Decreases 16-fold the affinity for PtdIns(3,4,5)P3. Ref.13 | ||||||
| Sequence conflict | 44 | 1 | D → G in CAD97968. Ref.4 | ||||||
| Sequence conflict | 304 | 1 | V → M in CAD97968. Ref.4 | ||||||
| Sequence conflict | 374 | 1 | E → V in CAD97968. Ref.4 | ||||||
| Sequence conflict | 423 | 1 | E → Q in AAP30843. Ref.1 | ||||||
| Sequence conflict | 423 | 1 | E → Q in AAP30845. Ref.1 | ||||||
| Sequence conflict | 423 | 1 | E → Q in AAN40768. Ref.1 | ||||||
| Sequence conflict | 473 | 1 | L → P in CAD97968. Ref.4 | ||||||
| Sequence conflict | 483 | 1 | F → S in AAP30845. Ref.1 | ||||||
| Sequence conflict | 483 | 1 | F → S in AAN40768. Ref.1 | ||||||
| Sequence conflict | 490 | 1 | V → E in CAD97968. Ref.4 | ||||||
| Sequence conflict | 548 | 1 | G → V in CAD97968. Ref.4 | ||||||
| Sequence conflict | 738 | 1 | I → L in AAP30845. Ref.1 | ||||||
| Sequence conflict | 738 | 1 | I → L in AAN40768. Ref.1 | ||||||
| Sequence conflict | 788 | 1 | V → A in AAP30845. Ref.1 | ||||||
| Sequence conflict | 788 | 1 | V → A in AAN40768. Ref.1 | ||||||
| Sequence conflict | 936 | 1 | E → G in CAI46011. Ref.4 | ||||||
| Sequence conflict | 985 | 1 | A → V in AAP30845. Ref.1 | ||||||
| Sequence conflict | 985 | 1 | A → V in AAN40768. Ref.1 | ||||||
| Sequence conflict | 1020 | 1 | G → A in AAP30843. Ref.1 | ||||||
| Sequence conflict | 1041 | 1 | L → P in AAP30845. Ref.1 | ||||||
| Sequence conflict | 1041 | 1 | L → P in AAN40768. Ref.1 | ||||||
| Sequence conflict | 1066 | 1 | V → L in AAP30842. Ref.1 | ||||||
| Sequence conflict | 1126 | 1 | A → T in CAI46011. Ref.4 | ||||||
| Sequence conflict | 1134 | 1 | M → V in CAI46011. Ref.4 | ||||||
| Sequence conflict | 1198 | 1 | P → R in CAI46011. Ref.4 | ||||||
| Sequence conflict | 1293 | 1 | H → M in AAP30845. Ref.1 | ||||||
| Sequence conflict | 1293 | 1 | H → M in AAN40768. Ref.1 | ||||||
| Sequence conflict | 1294 | 1 | D → T in AAP30845. Ref.1 | ||||||
| Sequence conflict | 1294 | 1 | D → T in AAN40768. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "CATSPER2, a human autosomal nonsyndromic male infertility gene." Avidan N., Tamary H., Dgany O., Cattan D., Pariente A., Thulliez M., Borot N., Moati L., Barthelme A., Shalmon L., Krasnov T., Ben-Asher E., Olender T., Khen M., Yaniv I., Zaizov R., Shalev H., Delaunay J. Beckmann J.S.Eur. J. Hum. Genet. 11:497-502(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 5). Tissue: Bone marrow, Testis and Trachea. |
| [2] | "Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro." Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 4:141-150(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7). Tissue: Brain. |
| [3] | Ohara O., Nagase T., Kikuno R., Nomura N. Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION. |
| [4] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4). Tissue: Endometrial adenocarcinoma. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 6). Tissue: Eye and Uterus. |
| [6] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [7] | "Cloning and characterization of two human VIP1-like inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinases." Fridy P.C., Otto J.C., Dollins D.E., York J.D. J. Biol. Chem. 282:30754-30762(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [8] | "Purification, sequencing, and molecular identification of a mammalian PP-InsP5 kinase that is activated when cells are exposed to hyperosmotic stress." Choi J.H., Williams J., Cho J., Falck J.R., Shears S.B. J. Biol. Chem. 282:30763-30775(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION. |
| [9] | "A conserved family of enzymes that phosphorylate inositol hexakisphosphate." Mulugu S., Bai W., Fridy P.C., Bastidas R.J., Otto J.C., Dollins D.E., Haystead T.A., Ribeiro A.A., York J.D. Science 316:106-109(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME ACTIVITY. |
| [10] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1152, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [12] | "Structural analysis and detection of biological inositol pyrophosphates reveal that the family of VIP/diphosphoinositol pentakisphosphate kinases are 1/3-kinases." Lin H., Fridy P.C., Ribeiro A.A., Choi J.H., Barma D.K., Vogel G., Falck J.R., Shears S.B., York J.D., Mayr G.W. J. Biol. Chem. 284:1863-1872(2009) [PubMed] [Europe PMC] [Abstract] Cited for: CATALYTIC ACTIVITY. |
| [13] | "Receptor-dependent compartmentalization of PPIP5K1, a kinase with a cryptic polyphosphoinositide binding domain." Gokhale N.A., Zaremba A., Shears S.B. Biochem. J. 434:415-426(2011) [PubMed] [Europe PMC] [Abstract] Cited for: BIOPHYSICOCHEMICAL PROPERTIES, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, POLYPHOSPHOINOSITIDE-BINDING DOMAIN, MUTAGENESIS OF ARG-399 AND ARG-417. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF502586 mRNA. Translation: AAP30842.1. AF502587 mRNA. Translation: AAP30843.1. AF502588 mRNA. Translation: AAP30844.1. AF502589 mRNA. Translation: AAP30845.1. AF543190 mRNA. Translation: AAN40768.1. AB002375 mRNA. Translation: BAA20831.2. Different initiation. BX538022 mRNA. Translation: CAD97968.1. BX647814 mRNA. Translation: CAI46011.1. BC050263 mRNA. Translation: AAH50263.1. BC057395 mRNA. Translation: AAH57395.1. |
| IPI | IPI00005663. IPI00218030. IPI00384259. IPI00398511. IPI00657657. IPI00738361. IPI00877721. |
| RefSeq | NP_001124330.1. NM_001130858.2. NP_001124331.1. NM_001130859.2. NP_001177143.1. NM_001190214.1. NP_055474.3. NM_014659.5. |
| UniGene | Hs.156814. Hs.679911. |
3D structure databases | |
| ProteinModelPortal | Q6PFW1. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000380129. |
PTM databases | |
| PhosphoSite | Q6PFW1. |
Polymorphism databases | |
| DMDM | 74758334. |
Proteomic databases | |
| PaxDb | Q6PFW1. |
| PRIDE | Q6PFW1. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000334933; ENSP00000334779; ENSG00000168781. ENST00000348806; ENSP00000308773; ENSG00000168781. ENST00000360135; ENSP00000353253; ENSG00000168781. ENST00000360301; ENSP00000353446; ENSG00000168781. ENST00000396923; ENSP00000380129; ENSG00000168781. ENST00000420765; ENSP00000400887; ENSG00000168781. |
| GeneID | 9677. |
| KEGG | hsa:9677. |
| UCSC | uc001zrw.3. human. uc001zrx.2. human. uc001zry.4. human. uc021sjz.1. human. |
Organism-specific databases | |
| CTD | 9677. |
| GeneCards | GC15M043826. |
| H-InvDB | HIX0012186. |
| HGNC | HGNC:29023. PPIP5K1. |
| HPA | HPA039380. |
| MIM | 610979. gene. |
| neXtProt | NX_Q6PFW1. |
| PharmGKB | PA165479401. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG245915. |
| HOVERGEN | HBG108657. |
| InParanoid | Q6PFW1. |
| KO | K13024. |
| OrthoDB | EOG41VK25. |
| PhylomeDB | Q6PFW1. |
Enzyme and pathway databases | |
| BioCyc | MetaCyc:HS09822-MONOMER. |
| Reactome | REACT_111217. Metabolism. |
Gene expression databases | |
| ArrayExpress | Q6PFW1. |
| Bgee | Q6PFW1. |
| Genevestigator | Q6PFW1. |
Family and domain databases | |
| InterPro | IPR000560. His_Pase_superF_clade-2. [Graphical view] |
| Pfam | PF00328. His_Phos_2. 1 hit. [Graphical view] |
| PROSITE | PS00616. HIS_ACID_PHOSPHAT_1. 1 hit. PS00778. HIS_ACID_PHOSPHAT_2. False negative. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChEMBL | CHEMBL5046. |
| ChiTaRS | PPIP5K1. human. |
| GenomeRNAi | 9677. |
| NextBio | 36337. |
| SOURCE | Search... |
Entry information
| Entry name | VIP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q6PFW1 Secondary accession number(s): O15082 Q8IZN0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 15 Human chromosome 15: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
